STOCK COMMENTS / EPS CHANGESBiogen Idec (BIIB - Get Report) numbers increased at Credit Suisse. BIIB estimates were raised through 2016, Credit Suisse said. Tysabri deal should add to earnings. Outperform rating and new $185 price target. Cigna (CI) numbers raised at Jefferies. Shares of CI now seen reaching $71, Jefferies said. Estimates also raised on its upward 2013 revision. Buy rating. Cisco (CSCO) target raised at Citigroup to $24, Citigroup said. Continued execution in an improving macro environment. Buy rating. Coinstar (CSTR) estimates, target cut at JP Morgan. CSTR estimates were reduced through 2014, JP Morgan said. Company is seeing lower sales. Neutral rating and new $51 price target. Eastman Chemical (EMN) target raised at Jefferies. Shares of EMN now seen reaching $79, Jefferies said. Favorable pricing in 2013. Hold rating. Google (GOOG) added to Best Ideas List at Morgan Stanley. Company can deliver 15% compound annual free cash flow growth over the next five years. $932 price target. CarMax (KMX) numbers raised at Oppenheimer. Shares of KMX now seen reaching $46, Oppenheimer said. Estimates also raised on attractive market share growth. Outperform rating. LinkedIn (LNKD) estimates, target raised at BMO. Shares of LNKD now seen reaching $130, according to BMO Capital. Estimates also increased, as new products are driving growth. Market Perform rating. Microchip Technology (MCHP) numbers raised at Jefferies. Shares of MCHP now seen reaching $41, Jefferies said. Estimates also raised on fourth quarter beat. Buy rating. Microchip estimates, target raised at Credit Suisse. Shares of MCHP now seen reaching $40, according to Credit Suisse. Estimates also increased, as the company is seeing higher core demand and benefits from acquisitions. Outperform rating. Martin Marietta (MLM) numbers raised at Jefferies. Shares of MLM now seen reaching $114, Jefferies said. Estimates also raised stronger demand enabling fourth quarter beat. Buy rating. NCR (NCR) estimates, target boosted at JP Morgan. Shares of NCR now seen reaching $37, according to JP Morgan. Estimates also upped, given the company's new guidance. Overweight rating. OpenTable (OPEN) numbers lowered at Oppenheimer. Shares of OPEN now seen reaching $49, Oppenheimer said. Estimates also lowered on slowing earnings growth. Perform rating. Patterson-UTI (PTEN) numbers upped at BMO. PTEN estimates were boosted through 2014, BMO Capital said. Company is seeing higher demand for pressure pumping. Outperform rating and new $25 price target. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.